Key statistics
On Friday, Tarsus Pharmaceuticals Inc (TARS:NSQ) closed at 34.51, -18.80% below its 52-week high of 42.50, set on May 09, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 34.62 |
---|---|
High | 34.93 |
Low | 33.73 |
Bid | 34.20 |
Offer | 36.77 |
Previous close | 34.60 |
Average volume | 712.61k |
---|---|
Shares outstanding | 38.04m |
Free float | 33.41m |
P/E (TTM) | -- |
Market cap | 1.31bn USD |
EPS (TTM) | -4.43 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference
- Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
- Tarsus to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
- Tarsus to Participate in Upcoming Investor Conferences
- Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
- Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements
- Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
- Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
- Tarsus to Participate at Upcoming Investor Conferences
- Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
More ▼